Kevin Eggan
Technik-/Wissenschafts-/F&E-Leiter bei BIOMARIN PHARMACEUTICAL INC.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Randy Meier | M | 65 | 18 Jahre | |
Kasper Roet | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Alexander Hardy | M | 56 | 1 Jahre | |
David Pyott | M | 70 | 8 Jahre | |
Stuart Bunting | M | - | 16 Jahre | |
Barbara Bodem | F | 56 | 1 Jahre | |
Elizabeth Anderson | F | 66 | 5 Jahre | |
George Davis | M | 53 | 20 Jahre | |
Athena Countouriotis | M | 52 | 1 Jahre | |
Philip Lo Scalzo | M | - | 17 Jahre | |
Willard Dere | M | 70 | 8 Jahre | |
Robert Hombach | M | 58 | 7 Jahre | |
Clifford J. Woolf | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Elaine Heron | M | 76 | 22 Jahre | |
May Kin Ho | M | 71 | 3 Jahre | |
Brian Mueller | M | 50 | 22 Jahre | |
Mark Enyedy | M | 60 | 1 Jahre | |
Erin Burkhart | F | 45 | 2 Jahre | |
Leonard van den Berg | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Philip Van Damme | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
C. Guyer | M | 62 | 4 Jahre | |
Humaira Serajuddin | F | - | 2 Jahre | |
Sourav Kole | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 2 Jahre |
Amy Schulman | F | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Michael Hutton | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Dame Shaw | F | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Ammar Al-Chalabi | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Ganesh Vedantham | M | - | 3 Jahre | |
Marni Kottle | F | - | - | |
Brad Glasscock | M | - | 12 Jahre | |
Cillian King | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Amy Wireman | F | - | 11 Jahre | |
Brinda Balakrishnan | M | 44 | 8 Jahre | |
Johannes Nielsen | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 6 Jahre |
Henry Fuchs | M | 66 | 15 Jahre | |
Dave Jacoby | M | - | 8 Jahre | |
Anne Michelle Whitaker | F | 56 |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 2 Jahre |
Traci McCarty | F | - | - | |
Jonathan Behr | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Eduardo Von Pervieux | M | - | 16 Jahre | |
Laia Crespo | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Luc Dochez | M | 49 |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Roel Bulthuis | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 4 Jahre |
Chris Thomajan | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jean-Jacques Bienaimé | M | 70 | 19 Jahre | |
Adora Ndu | M | 43 | 5 Jahre | |
Mark Alles | M | 64 | 2 Jahre | |
V. Lawlis | M | 72 | 17 Jahre | |
Michael Grey | M | 71 | 16 Jahre | |
Jeff Ajer | M | 61 | 19 Jahre | |
Dennis Joseph Slamon | M | 75 | 10 Jahre | |
Wayne T. Pan | M | 60 | 3 Jahre | |
Geoffrey Nichol | M | 69 | 5 Jahre | |
Debra Charlesworth | F | - | - | |
Lon Cardon | M | 58 | 4 Jahre | |
Benjamin Kim | M | - | 4 Jahre | |
Andrea Acosta | F | - | 5 Jahre | |
Harold Bernstein | M | - | 1 Jahre | |
Javier Szwarcberg | M | 54 | 2 Jahre | |
Edward Berg | M | - | 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 60 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kevin Eggan
- Persönliches Netzwerk